Is Now a Good Time to Buy Micron Stock? What the Anthropic Deal Tell Us

Micron stock doesn't move quietly anymore.

The company announced a strategic agreement with Anthropic on June 22, covering memory and storage architecture design, a multi year supply deal, and a direct investment in Anthropic's Series H round. Micron stock jumped over 6% on the news. 

Then on June 23, a macro driven selloff pulled it back sharply not because of anything Micron did, but because South Korean chip stocks crashed 10% and triggered a broader AI sector pullback that hit Micron stock alongside everything else in the space.

And today, Micron stock faces its biggest near-term test: fiscal Q3 earnings after the market close, with the options market pricing a roughly 17% move in either direction off the print.

Three days. Three completely different market dynamics. All pointing at the same underlying question: is now actually a good time to buy?

What the Anthropic Deal Actually Changes

Most supply agreements are transactional. A customer needs memory, a supplier delivers, both sides move on.

The Anthropic deal is structured differently. It covers memory and storage AI architecture design, a long-term supply agreement spanning Micron's full data center portfolio, enterprise adoption of Claude across Micron's own operations, and a strategic investment in Anthropic's funding round. The agreement directly links the demands of frontier AI models to how infrastructure is designed, supplied, and deployed at scale.

That last part matters. Micron isn't just selling memory to Anthropic, it's co-designing how memory and storage systems perform inside the most demanding AI workloads being built today. That kind of embedded relationship is harder to displace than a standard supply contract, and it signals something important about where Micron sits in the AI infrastructure stack.

Anthropic's co-founder and chief compute officer put it directly: memory and storage are central to how efficiently the company can train and serve Claude. That's not a peripheral vendor relationship. That's a core infrastructure partnership.

The Numbers Behind the Question

Before deciding whether now is a good time to buy Micron stock, it helps to understand what the business actually looks like right now.

Micron's most recent quarter posted revenue of $23.86 billion a record, and up more than 200% year over year for DRAM alone. For fiscal Q3, management guided for approximately $33.5 billion in revenue with roughly 81% gross margins. The sequential jump from $23.86 billion to $33.5 billion, if delivered tonight, would rank among the fastest revenue accelerations any large-cap semiconductor company has ever produced.

Analysts have noticed. Needham raised its price target to $1,550 ahead of earnings, citing continued strengthening in memory market fundamentals and long-term agreements giving suppliers demand visibility extending multiple years into the future. Bernstein reiterated its Buy rating at $1,300. UBS has a target of $1,625, arguing there is no reason Micron shouldn't trade like a high-flying chipmaker given AI demand. Raymond James pushed its target to $1,100 and was rewarded with a 6% single-day move when the note dropped.

The consensus among 30 analysts is a Buy rating. Wall Street expects fiscal 2026 earnings of $58.79 per share, up 665% year over year, with fiscal 2027 expectations at $102.26 per share.

Micron's HBM capacity is entirely sold out through 2026. Management has said the company can fulfill only 50% to two-thirds of memory orders for key customers meaning demand is running well ahead of what Micron can supply. Supply tightness across HBM, DRAM, and NAND is expected to persist well beyond calendar 2026, with new fabrication capacity not providing meaningful relief until fiscal 2028 at the earliest.

The Case for Buying Now

The structural argument for Micron stock is as strong as it has ever been.

Memory has stopped being a commodity business and started behaving like critical infrastructure. AI training and inference workloads require high bandwidth, high-capacity memory at scale and the supply of that memory is genuinely constrained. That combination of structural demand and limited supply is what drives the kind of pricing power and margin expansion Micron has been reporting.

The Anthropic deal adds another dimension. It's not just a supply win, it's a signal that Micron is being pulled deeper into the frontier AI development cycle in a way that extends visibility and reduces the quarterly guessing game about whether demand will hold.

If you invested $10,000 in Micron stock at the start of 2026, that position is now worth more than $30,000. The investors who have done best with Micron over the past year are the ones who understood the structural story and held through volatility rather than trying to trade the news cycle.

Micron has beaten consensus earnings expectations in eight of the past nine quarters. The company has been added to the S&P 100 Index, bringing institutional buying from index funds. And it was the third-best performer in the S&P 500 this year before today's earnings.

The Case for Waiting

The honest answer is that buying into a record high on an earnings day is a binary bet, not an investment thesis.

Micron stock hit an all-time high of $1,133 on June 18. The stock is sitting at a valuation that already reflects significant optimism a price to book ratio of 16.8 times, significantly higher than the sector median. Some analysts have flagged the stock as priced for perfection, where the upside surprise is partly spent while the downside gap is wide open.

The June 23 selloff created a technical setup that looks more interesting. Key support levels sit around $1,020 and $980 a zone the price has held several times as both support and resistance. If management sounds cautious on HBM volumes or pricing trajectory, the reaction will be worse. That asymmetry is real and worth taking seriously.

The smarter framing for most investors isn't whether to buy before or after tonight's print, it's whether the long-term case justifies exposure at all. If the answer is yes, waiting for the post-earnings reaction to clarify direction tends to produce better entries than buying directly into the uncertainty.